Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3

Author： Beck I.   Gerlach H.   Burkhardt E.   Kaleta E.F.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.9, 2003-02, pp. : 1006-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production

By Iyer A.V.   Ghosh S.   Singh S.N.   Deshmukh R.A.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1097-1105

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants

By Johansen K.   Schroder U.   Svensson L.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 368-375

Elsevier

Access to resources Recommend Favorite

Flt3 ligand and conjugation to IL-1 peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine

By Pisarev V.M.   Parajuli P.   Mosley R.L.   Chavez J.   Zimmerman D.   Winship D.   Talmadge J.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2358-2368

Elsevier

Access to resources Recommend Favorite

Further studies on the efficacy of a live vaccine against mastitis caused by Streptococcus uberis

By Finch J.M.   Winter A.   Walton A.W.   Leigh J.A.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1138-1143

Elsevier

Access to resources Recommend Favorite

Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness

By Preziosi M.-P.   Halloran M.E.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1853-1861

Elsevier

Access to resources Recommend Favorite